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Laparoscopic colon resection has established its role as a minimally invasive approach to colorectal diseases. Better long-term
survival rate is suggested to be achievable with this approach in colon cancer patients, whereas some doubts were raised about
its safety in rectal cancer. Here we report on our single centre experience of rectal laparoscopic resections for cancer focusing on
short- and long-term oncological outcomes. In the last 13 years, 248 patients underwent minimally invasive approach for rectal
cancer at our centre. We focused on 99 stage I, II, and III patients with a minimum follow-up period of 5 years. Of them 43 had
a middle and 56 lower rectal tumor. Laparoscopic anterior rectal resection was performed in 71 patients whereas laparoscopic
abdomino-perineal resection in 28. The overall mortality rate was 1%; the overall morbidity rate was 29%. The 5-year disease-free
survival rate was 69.7%, The 5-year overall survival rate was 78.8%.
1.Introduction
Laparoscopic colon resection has established its role as a
minimally invasive approach to colorectal diseases.
Somedoubtswereraisedaboutitsfeasibilityandsafetyin
rectal cancer because of concern related to thorough surgical
exploration in narrow pelvis and correct total mesorectal
excisionwiththelaparoscopictechnique.Theriskofportsite
metastases had also been previously emphasised [1, 2].
No conclusive data are available in this setting, and
further trials are deemed to be needed [3–6].
However, several studies demonstrated the technical
feasibility and safety of laparoscopic rectal resections for
cancer. Many authors showed advantages for laparoscopic
colorectal surgery in terms of reduced postoperative pain,
shorter postoperative ileus, and length of hospital stay
[3, 7–10]. As a medium-term advantage, a reduced rate
on incisional hernia should be considered [11]. A better
postoperative recovery, especially for older patients, was also
reported [12].
From an oncological point of view, the noninferiority
of colic laparoscopic surgery was established [13]. A better
long-term survival rate in colon cancer patients has been
suggested in some experiences [14].
Here we report on our rectal cancer patient series treated
with laparoscopic approach that was retrospectively analysed
focusing on functional results and oncological outcomes.
2. Patients andMethods
Three hundred and thirty-one patients with rectal cancer
underwent surgical treatment at our hospital from June 1997
to December 2010; 248 of them had minimally invasive
approach (192 laparoscopic—49 fully robotic).
We selected for this analysis 102 patients with a mini-
mum followup of 5 years, therefore excluding 146 patients
operated on after December 2005. Three more patients with
UICC Stage IV disease were also excluded. Eventually we
analysed99patients,43(45.7%)withamiddletumor(>8cm2 International Journal of Surgical Oncology
Table 1: Patients characteristics.
Characteristic Middle tumor (n = 43) Lower tumor (n = 56)
Mean age (range) 71 (42–96) 70 (42–91)
Gender
Males 25 34
Females 18 22
Stage TNM
I 8 (17%) 5 (42%)
II 13 (50%) 24 (30%)
III 22 (33%) 27 (28%)
from anal verge) and 56 with a low tumor (<8cmfromanal
verge).
A rectal anterior resection (RAR) was performed in
71 patients (71.7%) and a laparoscopic abdominoperineal
resection(APR)in28(28.3%).Allthepatientswereoperated
on by the same surgeon (GS).
A written and detailed informed consent was obtained
from each patient. Age at surgery, gender, pathological
tumor stage (according to the pTNM classiﬁcation), and
other relevant variables were prospectively recorded for each
patient in an appropriate data base implemented since the
beginning of our laparoscopic activity.
Preoperative workup included colonoscopy, contrast-
enhanced CT enema, thoracic CT, magnetic resonance of the
pelvis, and endorectal ultrasonography.
After preoperative assessment 68 patients (68%) with
extrarectal tumor diﬀusion (T3 stage) or nodal metastasis
(N+) received neoadjuvant radiochemotherapy.
Obesity or previous abdominal surgery was not consid-
ered contraindications for laparoscopic surgery.
All rectal resections were carried out with inferior
mesenteric vessel ligation and left ﬂexure detachment with
a medial-to-lateral approach.
Total mesorectal excision (TME) was performed in all
patients according to the Heald’s principles [15].
Bowel reconstruction was performed by Knight-Griﬀen
colorectal anastomosis.
J-pouch was used both in coloanal hand sewn anasto-
mosis and in mechanical anastomosis within 2cm from the
dentate line, whenever possible.
To preserve sphincter function in very low tumors,
bowel reconstruction was performed after intersphincteric
resection, by coloanal hand sewn anastomosis.
A diverting loop ileostomy was performed in 53 patients
undergone RAR (14 middle tumors, 39 lower tumors). In all
cases a wound protector was used to extract the specimen.
The clinical parameters analysed were patient variables,
operative variables, and clinical outcomes. Patient variables
were age at surgery, gender, and pathological tumor stage
(according to the pTNM classiﬁcation) (Table 1). Operative
variables included operating time and conversion rate.
Clinical outcomes were surgical complications, recurrence
rate, site of ﬁrst recurrence, disease-free survival, and overall
survival.
Table 2: Complications.
Complications No. of patient (%)
Urinary retention 8 (8%)
Anastomotic bleeding 5 (7%)
Wound infection 3 (3%)
Anastomotic leakage 3 (4,2%)
Small bowel obstruction 2 (2%)
Follow-up protocol included a medical examination and
serum CEA determination every 3 months for two years,
every 6 months for the third year, and annually thereafter.
An abdominal sonography, with systematic research of
liver metastasis, was performed every 6 months. Additional
radiological imaging (chest X-ray, CT scan, MRI scan, etc.)
was carried out if appropriate. A ﬂexible colonoscopy was
performed every year.
The cancer-speciﬁc disease-free survival rate was anal-
ysed with a minimum followup of ﬁve years: data were
considered as uncensored only if the patient died as a direct
result of colorectal cancer; deaths from all other causes were
censored.
The Kaplan-Meier method was used to plot the survival
curves, and the log-rank test was used for their comparison.
A P value of less than 0.05 was set as the statistical
signiﬁcance level.
Pearson’s chi-squared test, “t” test, or Fisher’s exact test
was used when appropriate.
Statistical analysis was performed with commercially
available software (SPSS version 13.0, SPSS Inc., Chicago, Ill,
USA).
3. Results
The age, distribution, and gender of the study population is
showed in Table 1.
Mean operating time was lower for middle rectal cancer
group (mean 210min.) than for low rectal cancer group
(mean 270min.) (P<0.01).
The conversion rate was 10%, mainly due to adhesions,
diﬃcult isolation of locally advanced bulky tumors, or septic
complications.
Thepostoperativemortalityratewas1%;therewas1fatal
complication, with postoperative death, due to multiorgan
failure in systemic candidiasis.
The overall morbidity rate was 29%.
Postoperative complications included 3/71 (4.2%) cases
of anastomotic leakage, 3/99 (3%) wound infections,
5/71(7%) anastomotic bleeding, 8/99 (8%) transitory uri-
nary retention, and 2/99 (2%) small bowel obstruction
(Table 2).
Patients with anastomotic leakage needed reintervention
with creation of a diverting ileostomy, peritoneal lavage, and
drainage.
There were no positive proximal, distal, or circumferen-
tial margins. The mean number of harvested lymph nodes
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Table 3: Local and distant recurrence.
Site of recurrence N = 27
Lung 13 (48%)
Liver 7 (25%)
Local 3 (11%)
Lymph nodes 2 (7%)
Peritoneum 1 (3%)
Brain 1 (3%)
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Figure 1: Overall survival.
After a median followup of 72 months (min 60 and
maximum 146), 21 (21,2%) patients died from colorectal
cancer and 27 (27,2%) had a cancer recurrence.
The most common site of recurrence was the lung,
followed by the liver. There were 3 cases of local recurrence
(Table 3). No cases of peritoneal seeding or portsite recur-
rence were reported.
The 5-year disease-free survival (DFS) rate was 69.7%
(Figure 1). The DFS stratiﬁed per stage was 75.6%, 65.7%,
and 65.2% for patients in stage I, stage II, and stage III,
respectively (Figure 2).
The 5-year overall survival (OS) rate was 78.8%
(Figure 3).TheOSstratiﬁedperstagewas87.8%,71.4%,and
73.9% for patients in stage I, stage II, stage III, respectively
(Figure 4).
4. Discussion and Conclusions
In this single centre series of 99 rectal cancer patients treated
with minimally invasive approach the 5-year DFS rate was
69.7% and the 5-year OS rate was 78.8%, with 10% of
conversion rate and 29% of overall morbidity rate.
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Figure 2: Disease-free survival.
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Figure 3: Overall survival stratiﬁed per stage.
Though laparoscopic colon surgery has gained popular-
itybecauseofitspositiveinﬂuenceonshort-termoutcome,it
should be kept in mind that the ﬁrst aim of colorectal cancer
surgery is to ensure oncological outcomes at least similar to
those of open surgery.
Rectal laparoscopic surgery is still a debated issue. The
MRC-CLASICC trial in 2005 [3] had reported impaired4 International Journal of Surgical Oncology
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Figure 4: Disease-free survival stratiﬁed per stage.
short-term outcomes after laparoscopic anterior resection
concluding that its use for rectal cancer could not be yet
justiﬁed. In 2008 Kim et al. [6] reported an increasing
tendency for positive circumferential margins, leak, and
local recurrence in laparoscopic resection for extraperitoneal
rectal cancer. The Cochrane Review [16] in 2008 concluded
that laparoscopic rectal resection with TME appears to have
clinically measurable short-term advantages in patients with
primary rectal cancer.
Its long-term impact on oncological endpoints awaits the
results from the on-going randomized trials.
Since 1997 in our surgical department laparoscopy has
been largely used and gradually replaced open surgery. We
started laparoscopic rectal cancer surgery at a very early
phase,andinthispaperwereportonlong-termoutcomeofa
large series of rectal cancer patients. Though acknowledging
the overt limitation of this retrospective study, the data have
been collected prospectively in an appropriate data base that
wasusedsincethebeginningofourlaparoscopicactivity.The
percentage of patients lost at followup in our series is less
than 5%. Our department is a referral center for advanced
laparoscopic surgery. This analysis was mainly undertaken
to assess our results in rectal cancer laparoscopic surgery,
being the evaluation of functional results and oncological
outcomes of the primary end point. At that time there was
still serious concern about possible inadequacy of tumour
and lymph nodes resection and risk of cancer dissemination
at the port sites.
The strength of our study consists in the series size and in
the length of followup.
The conversion rate was superimposable to that reported
in previous studies whereas the wound infection rate after
laparoscopic surgery seemed lower than that previously
reported for open colorectal surgery [17, 18].
From a functional point of view laparoscopic magni-
ﬁcation allows identifying and preserving hypogastric and
pelvic nerves during the IMA isolation, medium to lateral
dissection, and TME. Preservation of sexual function after
laparoscopic surgery is still a matter of debate. Ad hoc
questionnaire on sexual activity is not often administered in
clinical studies [19]. Even in our series we did not collect any
information in this regard.
In the same way we did not speciﬁcally study the urinary
function but we registered in our data base any clinically
relevant event including urinary tract symptoms: all but 8
patients in this series had the catheter removed within 2 days
after surgery and no permanent urinary dysfunction was
recorded.
The choice to perform a straight colorectal anastomosis
after rectal resection was due to the favourable functional
results (patient satisfaction) observed in our laparoscopic
and open surgery experience and the ease of implementation
of this procedure. The straight anastomosis is useful in
case of narrow pelvis, obese patients, diverticular colon
(contraindication to perform J-pouch), and limited colon
mobilization is needed.
Cochrane meta-analysis in 2008 compared three recon-
structive techniques after anterior rectal resection (straight,
J-pouch, coloplasty) by analyzing 9 RCTs on straight versus
J-pouch anastomosis: J-pouch seems superior for short-term
functionalresults(within8monthsfromtheoperation)with
the same complication rate, whereas long-term functional
results tend to overlap. Of note, the 9 RCTs were all been
published before 2002, and none of them considered the
laparoscopic approach [20].
With respect of the use of a diverting loop ileostomy,
although some reports indicate that diversion does not inﬂu-
ence the leakage rate, our results suggest that this could not
bethecase.Infactthelowerincidenceofanastomoticleakage
seems to correlate with the use of diverting loop ileostomy.
In line with previous studies our data suggests that
laparoscopic rectal resection provides similar oncological
long-term outcomes compared to open rectal resection (DFS
52.1%–81%, OS 52,9%–75,3) [17, 21–25]. The oncological
safety issues of laparoscopic approach, in terms of number of
harvested lymph nodes, recurrence rate, and cancer-related
survival, are all in line with those reported in Abraham’s
meta-analysis in 2004 [21].
We chose to limit our analysis to those patients with a
minimum followup of 5 years. Considering that most of the
cancer-related deaths occur within the ﬁrst two years after
surgery, such a long time frame seems to be enough to draw
some initial conclusions.
In conclusion, in an advanced laparoscopic surgical
setting, laparoscopic rectal resection is feasible and seems to
accomplishalmostthesameﬁve-yearsurvivalandrecurrence
rate as open rectal resections.
Based on the already demonstrated short- and medium-
term advantages of laparoscopic surgery and in light of our
experience, we support this approach and think that it could
deserve more extensive application.International Journal of Surgical Oncology 5
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